$3.2 Billion Worldwide Medical Microbiology Testing Technologies Industry to 2027 – Impact of COVID-19 on the Market

NEXT STORY
NexImmune Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of NEXI-001 in Relapsed Acute Myelogenous Leukemia (AML)
PREV STORY
Tampa General Hospital announces strategic partnership with Philips to innovate and improve patient experience
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nabriva Therapeutics to present data at ECCMID supporting ongoing Phase 3 clinical development program for lefamulin

VIENNA, Austria and KING OF PRUSSIA, Pa., April 13, 2017 (GLOBE NEWSWIRE) -- Nabriva ...

author_avatar
NASDAQ Market News

Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis

author_avatar
NASDAQ Market News

Algernon Pharmaceuticals Appoints Professor of Respiratory Medicine Dr. Jacky Smith to Its Medical and Scientific Advisory Board

author_avatar
NASDAQ Market News